Cargando…
Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
INTRODUCTION: Establishing efficacy of and molecular pathways for statins has the potential to impact incidence of Alzheimer's and age‐related neurodegenerative diseases (NDD). METHODS: This retrospective cohort study surveyed US‐based Humana claims, which includes prescription and patient reco...
Autores principales: | Torrandell‐Haro, Georgina, Branigan, Gregory L., Vitali, Francesca, Geifman, Nophar, Zissimopoulos, Julie M., Brinton, Roberta Diaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687291/ https://www.ncbi.nlm.nih.gov/pubmed/33283039 http://dx.doi.org/10.1002/trc2.12108 |
Ejemplares similares
-
Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
por: Branigan, Gregory L., et al.
Publicado: (2022) -
Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients
por: Torrandell-Haro, Georgina, et al.
Publicado: (2022) -
Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
por: Branigan, Gregory L., et al.
Publicado: (2022) -
Sex and APOE genotype differences related to statin use in the aging population
por: Dagliati, Arianna, et al.
Publicado: (2021) -
Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain
por: Branigan, Gregory L., et al.
Publicado: (2023)